A comprehensive new study utilizing prospective data from the Environmental influences on Child Health Outcomes (ECHO) cohort has delivered a definitive finding: there is no evidence of a link between neonatal male circumcision and the development of autism spectrum disorder (ASD). The study, published in JAMA Pediatrics, addresses a growing public concern fueled by recent political rhetoric and highlights the importance of rigorous, data-driven investigation in public health discourse.
Main Findings: Clearing the Air
The research, led by Monica McGrath, ScD, MHS, of the Johns Hopkins Bloomberg School of Public Health, analyzed data from nearly 2,800 boys across 14 ECHO sites in the United States. The findings provide a stark contrast to recent claims suggesting that the procedure—or the pain management protocols associated with it—might be a catalyst for neurodevelopmental conditions.
When adjusting for potential confounders, the researchers found that circumcision was not associated with an autism diagnosis (OR 0.83, 95% CI 0.59-1.17). Furthermore, when the team stratified the data to look at specific subgroups—including those born preterm and those admitted to the neonatal intensive care unit (NICU)—they found either an inverse association or no association at all. Most importantly, the study extended beyond clinical diagnoses, finding no correlation between circumcision and the presentation of autism-related traits or behavioral markers as measured by the Social Responsiveness Scale (SRS-2) and the DSM-5 autism spectrum problems subscale of the Child Behavior Checklist (CBCL).
"These findings may provide reassurance for families who are considering or have elected circumcision for their son," Dr. McGrath stated in an interview with MedPage Today.
A Chronology of Controversy
The study was spurred by a surge in public anxiety following comments made by U.S. Health Secretary Robert F. Kennedy Jr. in September 2025. Kennedy claimed that circumcised boys were twice as likely to develop autism, positing that the use of acetaminophen during the procedure was the primary driver of the increased risk. These remarks arrived during a period of heightened sensitivity, occurring only weeks after the White House issued warnings to pregnant women regarding the potential risks of prenatal acetaminophen use—a claim that itself lacks robust clinical consensus.
The political discourse surrounding these claims did not exist in a vacuum. It resurrected older, scientifically debunked theories that had circulated on the fringes of medical literature for over a decade. Dr. McGrath noted that her team felt a responsibility to act when they began receiving inquiries from friends, family, and colleagues. "We knew the ECHO cohort had relevant data to help investigate this question," she said. By leveraging the large-scale, longitudinal nature of the ECHO project, the team aimed to replace speculation with high-quality, peer-reviewed evidence.
Supporting Data and Methodology
To conduct the analysis, researchers focused on 2,771 male children within the ECHO cohort for whom precise data regarding neonatal circumcision within 28 days of birth were available. Of these, 66% had undergone the procedure prior to hospital discharge.
The data provided a detailed look at the reality of neonatal pain management. The researchers found that only 4% of circumcised infants received acetaminophen during the procedure, and only 7% received the medication in the 30 days following birth. Instead, the standard of care was heavily reliant on other methods: 72% of infants received nerve blocks, 59% were given oral glucose or sucrose, and 12% were treated with anesthetic cream.
The demographic breakdown of the study participants was diverse, with 69% identifying as white, 26% as Hispanic, 12% as multiple races, and 7% as Black. The average age of the mothers and fathers involved was 31.2 and 33.5 years, respectively. Autism diagnoses were confirmed either through parent reporting of a professional medical diagnosis or through standardized clinical assessments, with a mean age of diagnosis at 3.8 years.
The analytical rigor applied to the study was significant. By utilizing the SRS-2 and CBCL, the researchers were able to assess not just binary "autism/no autism" labels, but the nuanced spectrum of behavioral traits that often characterize neurodevelopmental differences. In every metric, the statistical output showed no meaningful link between the procedure and the development of these traits.
Expert Analysis: Why Previous Studies Failed
The study has been lauded by members of the medical community for correcting the record, particularly because it addresses the flaws in previous, widely cited "studies" that were often used to propagate the circumcision-autism myth.
Dr. David Mandell, ScD, of the University of Pennsylvania Perelman School of Medicine, who was not involved in the study, provided a scathing critique of the older, "poorly conducted" research that fueled the recent controversy. He identified two primary examples of flawed science that had been mischaracterized as evidence:
- The Ecological Fallacy: One study used circumcision rates as a proxy for acetaminophen use on a population level. The researchers in that instance had no individual-level data on who was circumcised, who was given medication, or who developed autism. In some cases, they even used the prevalence of specific religious groups as a proxy for circumcision, a methodology that is scientifically indefensible.
- The Danish Registry Error: Another study hypothesized that the trauma of circumcision causes autism. However, that study relied on Danish registry data where circumcision is extremely rare and typically performed in a religious context post-discharge. The boys who were circumcised in hospitals in Denmark were overwhelmingly those with pre-existing perinatal complications or those in the NICU. Because these boys were already at higher risk for neurodevelopmental issues due to their medical status, the study failed to control for the very factors that caused the autism, erroneously blaming the circumcision instead.
"You have to ask, which of these boys is getting circumcised in the hospital?" Dr. Mandell explained. "It’s going to be those who have perinatal complications and are in the NICU. These are risk factors for autism… yet the investigators didn’t control for that."
Implications for Public Health and Policy
The implications of the JAMA Pediatrics study are far-reaching. By utilizing a prospective cohort—the gold standard in longitudinal health research—the authors have provided a level of certainty that was previously absent.
Reassurance for Parents
For families facing the decision of whether to circumcise their newborns, this study removes a significant and unfounded source of fear. The decision regarding circumcision is deeply personal, often involving cultural, religious, and medical considerations. The removal of the "autism risk" variable from that decision-making process allows parents to focus on evidence-based medical outcomes rather than fear-mongering rhetoric.
The Danger of Politicizing Science
The episode serves as a cautionary tale regarding the rapid spread of medical misinformation. When political figures cite cherry-picked or poorly conducted studies, it can lead to widespread public anxiety and the questioning of standard medical practices. The JAMA Pediatrics study underscores the critical importance of maintaining public trust through transparent, high-quality science.
Future Research Directions
While this study provides robust evidence, the authors acknowledged its limitations. The study was restricted to hospital records, meaning that data on acetaminophen use outside of the clinical setting were not available, and residual confounding remains a possibility in any observational study. Furthermore, the findings are specific to the U.S. hospital setting and may not be generalizable to all cultural contexts.
Moving forward, the researchers hope that the ECHO cohort will continue to provide the data necessary to answer parents’ most pressing questions about child health. By focusing on environmental exposures and developmental outcomes, the NIH-funded program remains a vital resource for ensuring that public health policies are built on solid, verifiable foundations rather than the shifting sands of political convenience.
In conclusion, the message from the medical community is clear: the supposed link between circumcision and autism is a phantom born of misinterpreted data and flawed study designs. Parents and providers can move forward with the knowledge that this specific neurodevelopmental fear has no basis in clinical reality.
